39
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma

, , , , , , , , & show all
Pages 437-444 | Published online: 13 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kaikai Zhao, Zhaoqin Huang, Youjiao Si, Liangchao Sun, Jinming Yu & Xiangjiao Meng. (2021) Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus. Cancer Management and Research 13, pages 613-623.
Read now

Articles from other publishers (4)

Sari Zemerly, Krija Thurairajasingam, Bassam Deeb & Michael Tilby. (2023) Small Cell Oesophageal Carcinoma: A Retrospective Case Series From a UK Tertiary Centre and a Review of the Literature. Cureus.
Crossref
Kaikai Zhao, Lin Ma, Lei Feng, Zhaoqin Huang, Xiangjiao Meng & Jinming Yu. (2021) CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus. Frontiers in Molecular Biosciences 7.
Crossref
Tao Li, Sijia Chen, Zongkai Zhang, Limei Lin, Qian Wu, Jinluan Li & Qin Lin. (2021) Chemotherapy Plus Radiotherapy Versus Radiotherapy in Patients With Small Cell Carcinoma of the Esophagus: A SEER Database Analysis. Cancer Control 28, pages 107327482198932.
Crossref
Mohammad Alfayez. (2020) Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities. World Journal of Clinical Oncology 11:10, pages 836-843.
Crossref